Showing results (1121-1130 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 5, 1997
Strategies to improve the cost effectiveness of general practitioner prescribing. An international perspectiveH McGavockPharmacoeconomics|August 5, 1997
Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trialC A Uyl-de Groot, E Vellenga, E G de Vries, et al.Pharmacoeconomics|August 5, 1997
Cost effectiveness of hepatitis A virus immunisation in SpainJ M Arnal, O Frisas, R Garuz, et al.Pharmacoeconomics|August 5, 1997
A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patientsR J Milne, S Vander Hoorn, R T JacksonPharmacoeconomics|August 6, 1994
Therapy of acute otitis media. Clinical and economic aspectsR Sagraves, W MaishPharmacoeconomics|August 6, 1994
The burden of migraine. A review of cost to societyR B Lipton, W F Stewart, M Von KorffPharmacoeconomics|October 5, 1994
Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapyS P McKenna, L C DowardPharmacoeconomics|October 5, 1994
Chemonucleolysis versus surgical discectomy for sciatica secondary to lumbar disc herniation. A cost and quality-of-life evaluationR Launois, B Henry, J R Marty, et al.Pharmacoeconomics|October 5, 1994
Economic evaluation of immunoprophylaxis in children with recurrent ear, nose and throat infectionsK Banz, D Schwicker, A M ThomasPharmacoeconomics|November 4, 1994
Quality-of-life instruments in hypertensionC J Bulpitt, A E FletcherPageof 336